Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2013 Fourth Quarter And Full Year Financial Results
( PR Newswire) “In 2014, we expect to focus our resources on advancing those programs through ….focused on developing breakthrough treatments for human disease.
Bioelectronics Corp. (OTCMKTS:BIEL) Returns to Growth
( HotStocked) BIEL has been picking up in volumes, if not price, in the past few months, as it supplied positive news on its pain management technology.
